sciFLEXARRAYER S12

The Bridge from R&D to Pilot Production

The sciFLEXARRAYER S12 is a medium-batch microdispensing workhorse for labs moving beyond prototyping. With larger target capacity (up to 12 standard microplates) and up to eight channels, S12 accelerates screening campaigns and small-scale manufacturing while maintaining the drop control, positional accuracy and reproducibility the platform is known for. It supports picoliter dispensing as standard and nanoliter as a custom option, plus application-dedicated software packages that streamline routine runs. If S3 proves the concept, S12 helps you industrialize it, efficiently, repeatably, and without changing technology.

Trusted by leading institutions

droplet

Non-contact liquid dispensing

aim

Ultra-high position precision

drop-ruler

Ultra-high volume accuracy

Microtiter

Up to 12 target standard microplates

2droplets

All liquids, including high viscosity

efficiency-gauge

Minimal dead volume

Benefits
The S12 is the ideal platform for labs transitioning from research to pilot production. It’s built to handle medium-throughput applications with ease, maintaining the same precision and reliability as the rest of the sciFLEXARRAYER range, with the speed and consistency needed to bridge R&D and production.
Like all sciFLEXARRAYER, the S12 features an open hardware and software architecture, allowing labs to integrate new tools, modules, or protocols as needs evolve. From application-specific add-ons to future hardware expansions, this openness reduces the risk of technical lock-in and extends the lifetime value of your investment. 

With support for up to 12 microtiter plates or 70 microscope slides, the S12 offers a versatile deck layout that increases throughput without compromising precision. It’s well suited for workflows that require multiple sample types or higher-volume runs, accelerating development. 

The S12 shares the same core dispensing platform as all sciFLEXARRAYER systems, ensuring precision, efficiency, and workflow compatibility from R&D to production. 

Key Features
1

UP TO 8 DISPENSING CAPILLARIES WITH INDIVIDUAL CONTROLS

2

Head camera for position control and QC of targets after spotting

3

High precision and high speed XYZ drives

4

UP to 70 STANDARD MICROSCOPE slides or 12 MTP plates PER RUN

5

ROBUST ENCLOSURE: NO VIBRATIONS, HIGH PRECISION

6

COMPACT FOOTPRINT (1.3 x 0.8 x 1.2 m)

7

TARGET DECK, WITH STANDARD, or VACCUUM TARGET HOLDER

8

PC CONTROL WITH FLEXIBE RUN AUTOMATION AND LIVE VISUAL CONTROL OF DROPLET STABILITY

Precision microdispensing applications

Case Study

PRECISION ARRAY PRINTING WITH SCIFLEXARRAYER S12

The Challenge

Mapping complex immune responses.

Researchers at the Max Planck Institute of Colloids and Interfaces, Germany, and the University of Exeter, sought to decode the antibody response to Candida infections in humans and mice. Precise, high throughput glycan microarrays were required to screen synthetic fungal glycans and identify diagnostic and vaccine targets.

The Solution

Automated picoliter  dispensing for  synthetic glycans.

Using the sciFLEXARRAYER S12, 29 defined mannan and βglucan structures were printed as uniform microarrays on NHS activated slides. The S12’s non-contact piezo dispensing ensured accurate spot volumes (~100 pL) and precise pattern alignment across 64 replicate fields. Automated drop control and humidity stabilization provided clean, reproducible spots suitable for fluorescence assays and long-term stability testing.

The Outcome

Uncovering biomarkers for diagnostics and  vaccines.

The high-quality arrays enabled the team to map IgG and IgM responses against specific synthetic glycans, revealing distinct mannan signatures that differentiate major Candida species. Published in PNAS (2025), the study identified lead oligosaccharide epitopes for next generation diagnostic tests and glycoconjugate vaccine development, demonstrating the power of the S12 for precision array printing in infectious disease research.

Glycan microarray analysis of Candida-related antibodies in human and mice sera guides biomarker discovery and vaccine development

Emelie E. Reuber, Emer Hickey, et al
PNAS, 2025

Other products in the sciFLEXARRAYER range